Pfizer Inc. (PFE) Presents at Goldman Sachs 44th Annual Global Healthcare Conference Call TranscriptSeeking Alpha • 06/13/23
U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for Pfizer's BRAFTOVI® (encorafenib) in Combination With Cetuximab to Identify Patients With BRAF V600E Alterations in Metastatic Colorectal CancerBusiness Wire • 06/09/23
Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 26 million sales milestone payments to BasileaGlobeNewsWire • 06/08/23
Phase 3 Studies of Pfizer's Novel Antibiotic Combination Offer New Treatment Hope for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsBusiness Wire • 06/01/23
Dividend Harvesting Portfolio Week 117: $11,700 Allocated, $980.26 In Projected DividendsSeeking Alpha • 06/01/23
Excision BioTherapeutics Appoints Former Pfizer Chairman and CEO Jeffrey B. Kindler to its Board of DirectorsGlobeNewsWire • 06/01/23